How Much Does Gene analysis of 311 or more genes associated with solid organ cancer in cell-free dna, targeted sequence panel Cost on Medicare?

Cost analysis for CPT 0239U — Gene analysis of 311 or more genes associated with solid organ cancer in cell-free dna, targeted sequence panel

Average Medicare Payment

$3424.32

2023 data

Total Payments (2023)

$24.6M

Services (2023)

7.2K

Price Change (2021–2023)

-2.0%

📈 Year-over-Year Cost Trend

Year	Avg Payment	Total Payments	Services	YoY Change
2021	$3495.15	$25.4M	7.3K	—
2022	$3450.50	$23.5M	6.8K	-1.3%
2023	$3424.32	$24.6M	7.2K	-0.8%

🗺️ State-by-State Cost Variation

The most expensive state pays 1.0x more than the cheapest for this procedure. MA averages $3424.32 vs MA at $3424.32.

State	Avg Payment	Total Payments	Services	Providers
MA	$3424.32	$24.6M	7.2K	1

💰 Who Bills the Most for This Procedure?

Provider	Specialty	State	Payments	Services	Avg/Service
Foundation Medicine, Inc.	Clinical Laboratory	MA	$24.6M	7.2K	$3424.32

🤔 Is Gene analysis of 311 or more genes associated with solid organ cancer in cell-free dna, targeted sequence panel Overpriced?

Based on the data, CPT 0239U shows a 1.0x variation in pricing across states — relatively consistent by Medicare standards.

Costs have decreased 2% since 2021. Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.

This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.

Data Sources

• Centers for Medicare & Medicaid Services (CMS)
• Medicare Provider Utilization and Payment Data (2014-2023)
• Medicare Physician Fee Schedule

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.